key: cord-0868598-ejwz2ikb
authors: Yuzuak, Erdem; Aslan, Serdar; Cakir, Ismet Mirac
title: Pneumothorax in a COVID-19 Patient Receiving Long-Term Mechanical Ventilation
date: 2021-07-23
journal: Revista da Sociedade Brasileira de Medicina Tropical
DOI: 10.1590/0037-8682-0376-2021
sha: e59409dc21bde80195684b5b27f35e7dcdb36db4
doc_id: 868598
cord_uid: ejwz2ikb

nan

A 58-year-old woman reported to the clinic while being followed up after a diagnosis of COVID-19. She was administered favipiravir, dexamethasone, moxifloxacin, and a carbapenem. On the sixth day of treatment, she was admitted to the intensive care unit and intubated due to an oxygen saturation of 80-85% with an oxygen mask and the development of dyspnea and tachypnea. She was followed up in the intensive care unit for a month while mechanical ventilation, and she had worsening respiratory acidosis and elevated airway pressure. The general condition of the patient deteriorated, and chest CT showed left pneumothorax. In addition, there were bronchial enlargements, consolidated areas, and pleural effusion accompanied by diffuse ground-glass opacity in the thoracic CT scan (Figure 1, arrow) .

Pneumothorax and pneumomediastinum are relatively common complications in patients with extensive alveolar damage requiring mechanical ventilation 1 . In lung areas exposed to high pressure during mechanical ventilation, alveolar rupture may develop and cause pneumothorax 2 . Cases of spontaneous pneumothorax have also been reported in patients who are not intubated with COVID-19 3 . According to one hypothesis, cystic and fibrotic changes in the lung parenchyma during the early stages of COVID-19 may be the cause of the predisposition to pneumothorax 3 .

COVIDBioB Study Group. Predictors of Pneumothorax/Pneumomediastinum in Mechanically Ventilated COVID-19 Patients

Pneumothorax as an Ominous Side Effect in COVID-19 Patients under Mechanical Ventilation: Report of Seven Patients

COVID-19 and pneumothorax: a multicentre retrospective case series

Not Applicable.